Jacques Lebreton

Title: Jacques Lebreton: Innovator in Pharmaceutical Compounds

Introduction

Jacques Lebreton is a notable inventor based in Nantes, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of proliferative diseases. With a total of four patents to his name, Lebreton's work has the potential to impact cancer treatment and other medical applications.

Latest Patents

Lebreton's latest patents include innovative compounds such as disulfonate stilbenes, which are designed for use in the treatment of proliferative diseases. These compounds are characterized by a general formula where R and R' can be independently selected from hydrogen and pharmaceutically acceptable cations. Additionally, he has developed a pharmaceutical composition that may include another active ingredient, particularly an antineoplastic agent. Another significant patent involves inhibitors of RAC1, which are aimed at treating various cancers. This compound is defined by a specific formula that highlights its potential therapeutic applications.

Career Highlights

Throughout his career, Jacques Lebreton has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Nantes. His research and innovations have contributed to advancements in medical science, particularly in oncology.

Collaborations

Lebreton has collaborated with notable colleagues, including Vincent Sauzeau and Gervaise Loirand. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical field.

Conclusion

Jacques Lebreton's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex compounds and their applications in treating serious diseases.